The Latest Medical News

A Summary of The Latest Medical News: **A Weekly Injection Could Transform Parkinson’s Treatment** A team of scientists has developed a new long-acting injectable treatment that combines **levodopa** and **carbidopa**, the main medications for Parkinson’s disease[1][2][3][4][5]. This innovation could fundamentally change how patients manage the condition, allowing them to move from taking several pills each day to just a single injection per week[1][2][3][4][5]. **The Challenge of Parkinson’s Medication** Parkinson’s disease, the world’s second most common neurological disorder, causes symptoms like tremors, stiffness, and slowed movement[3]. Currently, patients must take levodopa—the gold-standard therapy—multiple times daily because its effects wear off quickly[1][2][3][4]. This constant need for dosing is a heavy burden and can lead to inconsistent drug levels and side effects[3]. **How the New Injection Works** Researchers at the University of South Australia designed an **injectable gel** that forms an implant under the skin and steadily releases both levodopa and carbidopa over an entire week[2][4][5]. The gel uses a biodegradable polymer (PLGA) and a pH-sensitive polymer (Eudragit L-100) to control the release of medication[1][2][3][4][5]. **Key Lab Findings** Laboratory tests showed: - Over **90% of the levodopa** and **81% of the carbidopa** doses were released over seven days[1][2][3][4][5]. - The implant degraded by more than **80% within a week** and showed **no significant toxicity** in cell viability tests[1][2][3][4][5]. - The injection is given with a fine **22-gauge needle**—similar to those used for blood draws—making it minimally invasive and avoiding the need for surgery[1][2][3][4][5]. **Patient Benefits** By maintaining more stable drug levels and reducing dose frequency, the weekly injection could relieve the daily challenges many patients face[1][2][3][4]. Scientists say this is not just about making drug delivery easier; it could significantly improve patients’ quality of life[1][2][3][4][5]. **What Comes Next?** While results so far are promising, the treatment still needs to undergo clinical trials in humans to confirm safety and effectiveness[5]. The research team is optimistic that these trials will start soon[5]. **Broader Impact** Researchers believe this injectable technology could also be adapted to help treat other chronic illnesses—like diabetes, cancer, pain, and infections—that require long-term, consistent medication delivery[4]. **Summary** A once-a-week injectable gel for Parkinson’s has the potential to be a game-changer, replacing the burden of multiple daily pills with a single shot that could keep symptoms at bay for an entire week[1][2][3][4][5]. Help with your insurance? https://tally.so/r/n012P9